Neuromod Successfully Closes €10.5 Million Series B Financing for Tinnitus Treatment Device Lenire®
The investment was led by majority investor Fountain Healthcare Partners, with participation from existing investors Moffett Investment Holdings and Medical Device Resources, with venture-debt provided by Kreos Capital and Silicon Valley Bank.